Gastritis
Gastritis is the inflammation and swelling of the stomach lining, which can be either acute or chronic, often caused by medications, heavy alcohol use, or infections. Symptoms may include upper abdominal pain, nausea, bloating, and heartburn, with potential complications such as stomach bleeding, ulcers, tumors, and pernicious anemia.
Health Outcomes
- Alleviated Alcohol-Induced Gastric Ulcers
- Binding to Goblet Cell Mucus
- Colonization of Gastrointestinal Tract by L. reuteri
- Disrupted Mucosal Barrier
- Enhanced Digestive Process Survival
- Enhanced Gastric Mucosal Defense
- Enhanced Gastric Protein Protection
- Enhanced Gastric Viability
- Enhanced Gastrointestinal Stress Resistance
- Enhanced Gut Health
- Enhanced Mucosal Protection
- Enhanced Survival under Gastrointestinal Stress
- Enhanced Vagal Nerve Activity in the Stomach
- Enhanced Viability in Acidic Conditions
- Gastrointestinal Tract Persistence
- Good Tolerance to Lactobacillus Reuteri
- Improved Abdominal Pain
- Improved Abdominal Pain Severity
- Improved Digestibility
- Improved Digestive Comfort
- Improved Digestive Efficiency
- Improved Digestive Function
- Improved Digestive Symptoms
- Improved Digestive Viability
- Improved Functional Dyspepsia Symptoms
- Improved Gastric Acid Regulation
- Improved Gastric Mucosal Protection
- Improved Gastric Survival
- Improved Gastric Tolerance
- Improved Gastrointestinal Discomfort
- Improved Gastrointestinal Function
- Improved Gastrointestinal Health
- Improved Gastrointestinal Resistance
- Improved Gastrointestinal Score
- Improved Gastrointestinal Symptom Management
- Improved Gastrointestinal Symptom Rating Scale Score
- Improved Gastrointestinal Symptom Relief
- Improved Gastrointestinal Symptoms
- Improved Gastrointestinal Tolerance
- Improved Gastrointestinal Viability
- Improved Gastrointestinal Well-Being
- Improved General GI Health Status
- Improved Gut Adhesion
- Improved Gut Dysbiosis
- Improved Gut Integrity
- Improved Gut Microbiome Composition
- Improved Gut Microbiome Recovery
- Improved Gut Mucosa Health
- Improved H Pylori Eradication Rates
- Improved Immunological Status of Mucosa
- Improved Iron Deficiency Anemia Treatment Efficacy
- Improved Iron Levels
- Improved Mucosal Barrier Function
- Improved Mucosal Visibility
- Improved Overall Gastric Symptoms
- Improved Overall Gastrointestinal Symptoms
- Improved Progressive Motility
- Improved Protection Against Helicobacter pylori
- Improved Survival Through Digestive Tract
- Improved Survival in Gastroduodenal Environment
- Increased Acetic Acid Production
- Increased Bloating
- Increased Digestive Problem
- Increased Emesis
- Increased Fullness
- Increased Gastric Acid Production
- Increased Gastric Cancer Risk
- Increased Gastric Epithelial Stem/Progenitor Cell Proliferation
- Increased Gastric Survival Rate
- Increased Gastrointestinal Discomfort
- Increased Gastrointestinal Symptoms
- Increased Gut Lactobacillus plantarum Population
- Increased H. pylori Eradication Rate
- Increased Helicobacter pylori Eradication Rate
- Increased IPA Levels
- Increased Incidence of Abdominal Symptoms
- Increased Sarcina Levels
- Increased Serum Gastrin Levels
- Increased Serum Gastrin-17 Level
- Increased Serum Pepsinogen Activity
- Increased Tolerance to Gastrointestinal Conditions
- Increased Total Acidity Levels
- Increased Total Anaerobic Gram-Positive Bacteria Counts
- Increased Total Bacterial Abundance
- Maintained Gastric Mucin Integrity
- Maintained Gastrointestinal Health
- Maintained Gut Health
- Maintained Healthy Gut Environment
- Maintained Mucosal Barrier Integrity
- Maintained Normal Mucosal Barrier Function
- No Significant Change in Duration of Gastrointestinal Symptoms
- No Significant Change in Gastrointestinal Symptoms
- No Worsening of Gastrointestinal Symptoms
- Preserved Gastrointestinal Histological Structure
- Protected Epithelial Cells Under Inflammatory Conditions
- Protection Against Gut Tissue Damage
- Reduced Abdominal Discomfort
- Reduced Abdominal Pain
- Reduced Abdominal Pain Frequency
- Reduced Abdominal Symptoms
- Reduced Acidification in Pineapple Juice
- Reduced Acidity
- Reduced Bloating Severity
- Reduced Cellular Invasion by Enterovirulent Bacteria
- Reduced Community-Acquired Gastrointestinal Infections
- Reduced Digestive Symptoms
- Reduced Dyspepsia Symptoms
- Reduced Epigastric Discomfort
- Reduced Epigastric Pain
- Reduced Expression of Cag Pathogenicity Island Genes in H. pylori
- Reduced Gastric Acid Secretion
- Reduced Gastric Cell Death
- Reduced Gastric Emptying
- Reduced Gastric Emptying Time
- Reduced Gastric Epithelial Proliferation Signaling
- Reduced Gastric Inflammation
- Reduced Gastric Injury
- Reduced Gastric Mucosal Histiocyte Numbers
- Reduced Gastric Mucosal Histiocytes
- Reduced Gastric Mucosal Inflammation
- Reduced Gastric Mucosal Injury
- Reduced Gastric Mucosal Lesion Formation
- Reduced Gastric Ornithine Decarboxylase Activity
- Reduced Gastric Polyamine Levels
- Reduced Gastric Symptoms
- Reduced Gastric Tissue Damage
- Reduced Gastric Volume
- Reduced Gastritis Symptoms
- Reduced Gastrointestinal Discomfort Symptoms
- Reduced Gastrointestinal Disease Symptoms
- Reduced Gastrointestinal Disorder Symptoms
- Reduced Gastrointestinal Disorders
- Reduced Gastrointestinal Inflammation
- Reduced Gastrointestinal Leakage
- Reduced Gastrointestinal Symptom Rating Scale Score
- Reduced Gastrointestinal Symptom Severity
- Reduced Gastrointestinal Symptoms Score
- Reduced Gastrointestinal Tract Histological Damage
- Reduced Gut Damage
- Reduced Gut Inflammation
- Reduced H. pylori Infection
- Reduced H. pylori Infection Severity
- Reduced H. pylori Levels
- Reduced Helicobacter Abundance
- Reduced Helicobacter Pylori Treatment-Related Symptoms
- Reduced Helicobacter pylori Colonization
- Reduced Helicobacter pylori-Related Gastritis
- Reduced IL-8 Production in Gastric Epithelial Cells
- Reduced Incidence of Ulcers
- Reduced Inflammation in Gastric Cells
- Reduced Inflammatory Response to Helicobacter pylori
- Reduced Intragastric Bacterial Load
- Reduced Mucosal Damage
- Reduced Mucosal Inflammation
- Reduced Mucosal Thickness
- Reduced NSAID Consumption
- Reduced Nausea Severity
- Reduced Pepsinogen Production
- Reduced Postprandial Discomfort
- Reduced Postprandial Fullness
- Reduced Prevalence of Gastric Symptoms
- Reduced Pyloric Pressure
- Reduced Severity of Gastrointestinal Disorders
- Reduced Ulcer Symptoms
- Reduced Ulcers Caused by ASA
- Reduced Urease Activity
- Reduced Vomiting Incidence
- Regression of Gastrointestinal Disorders
- Regulated Host Epithelial Cells
- Relieved Abdominal Dysfunction
- Relieved Gastrointestinal Symptoms
- Relieved Postprandial Discomfort
- Restored Goblet Cell Count
- Restored Mucus Layer Integrity
- Suppressed H. Pylori Infection
- Suppressed H. pylori Growth In Vivo
- Suppressed Helicobacter pylori
- Unchanged Gastrointestinal Symptoms